PDMI (PDMI) Stock Price & Analysis
PDMI (PDMI) rose 0.00% to USD 0 as of June 10, 2026 at 03:30 UTC, according to Nexqual real-time market data.
PDMI last closed at USD 0; the session ranged USD 0–0 on volume of 14,744,121 shares. Market capitalization is $324,878, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 03:30 UTC.
Key Statistics (as of June 10, 2026 at 03:30 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 14,744,121 shares |
| Market Cap | $324,878 |
| Exchange | PNK |
Technical Analysis (PDMI)
Nexqual's technical model rates PDMI "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:30 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (PDMI)
Wall Street analysts rate PDMI "None", per Nexqual as of June 10, 2026 at 03:30 UTC.
| Consensus Rating | None |
|---|
Earnings (PDMI)
Source: Nexqual, June 10, 2026 at 03:30 UTC.
Financials & Fundamentals (PDMI)
| Total Revenue | $757,000 |
|---|---|
| Revenue Growth (YoY) | -7.70% |
| Gross Margin | +69.88% |
| Operating Margin | -20.99% |
| Profit Margin | -45.58% |
| Current Ratio | 0.18 |
| Total Cash | $21,000 |
| Total Debt | $2.19M |
| Free Cash Flow | $229,875 |
Source: Nexqual, June 10, 2026 at 03:30 UTC.
Financial Health Score (PDMI)
Nexqual rates PDMI's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:30 UTC.
| Growth | Weak — Revenue -8% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $21K cash vs $2M debt |
| Cash Flow | Strong — FCF $230K, 30% margin |
| Efficiency | Mixed — No data |
Ownership (PDMI)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 3.25B |
Source: Nexqual, June 10, 2026 at 03:30 UTC.
Leadership (PDMI)
PDMI is led by Charles S. Pritchard, Vice President of Sales and Marketing, per Nexqual as of June 10, 2026 at 03:30 UTC.
| Vice President of Sales and Marketing | Charles S. Pritchard |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IGNT | INGEN TECHNOLOGIES INC | USD 0 | ▲ 0% |
| ASFX | AMERICAN SCIENTIFIC RESOURCES I | USD 0 | ▲ 0% |
| HTDS | HARD TO TREAT DISEASES INC | USD 0 | ▲ 0% |
| LLBO | Lifeline BioTechnologies, Inc. | USD 0 | ▲ 40% |
| WLSI | WELLSTAR INTERNATIONAL INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:30 UTC. This page is informational and not investment advice.